Multicentric validation of radiomics findings: challenges and opportunities
- PMID: 31474549
- PMCID: PMC6796519
- DOI: 10.1016/j.ebiom.2019.08.054
Multicentric validation of radiomics findings: challenges and opportunities
Comment on
-
Radiomic analysis for pretreatment prediction of response to neoadjuvant chemotherapy in locally advanced cervical cancer: A multicentre study.EBioMedicine. 2019 Aug;46:160-169. doi: 10.1016/j.ebiom.2019.07.049. Epub 2019 Aug 6. EBioMedicine. 2019. PMID: 31395503 Free PMC article.
Similar articles
-
Radiomics-based prediction of two-year clinical outcome in locally advanced cervical cancer patients undergoing neoadjuvant chemoradiotherapy.Radiol Med. 2022 May;127(5):498-506. doi: 10.1007/s11547-022-01482-9. Epub 2022 Mar 24. Radiol Med. 2022. PMID: 35325372 Free PMC article. Review.
-
Multi-modal radiomics model to predict treatment response to neoadjuvant chemotherapy for locally advanced rectal cancer.World J Gastroenterol. 2020 May 21;26(19):2388-2402. doi: 10.3748/wjg.v26.i19.2388. World J Gastroenterol. 2020. PMID: 32476800 Free PMC article.
-
External validation of a combined PET and MRI radiomics model for prediction of recurrence in cervical cancer patients treated with chemoradiotherapy.Eur J Nucl Med Mol Imaging. 2019 Apr;46(4):864-877. doi: 10.1007/s00259-018-4231-9. Epub 2018 Dec 7. Eur J Nucl Med Mol Imaging. 2019. PMID: 30535746
-
[The role of neoadjuvant chemotherapy for cervical cancer].Nihon Rinsho. 2012 Jun;70 Suppl 4:246-50. Nihon Rinsho. 2012. PMID: 23156250 Japanese. No abstract available.
-
Radiomics in cervical cancer: Current applications and future potential.Crit Rev Oncol Hematol. 2020 Aug;152:102985. doi: 10.1016/j.critrevonc.2020.102985. Epub 2020 May 24. Crit Rev Oncol Hematol. 2020. PMID: 32497972 Review.
Cited by
-
Advancing Hepatocellular Carcinoma Management Through Peritumoral Radiomics: Enhancing Diagnosis, Treatment, and Prognosis.J Hepatocell Carcinoma. 2024 Nov 4;11:2159-2168. doi: 10.2147/JHC.S493227. eCollection 2024. J Hepatocell Carcinoma. 2024. PMID: 39525830 Free PMC article. Review.
-
Effects of Tracer Uptake Time in Non-Small Cell Lung Cancer 18F-FDG PET Radiomics.J Nucl Med. 2022 Jun;63(6):919-924. doi: 10.2967/jnumed.121.262660. Epub 2021 Dec 21. J Nucl Med. 2022. PMID: 34933890 Free PMC article.
-
Identifying Robust Radiomics Features for Lung Cancer by Using In-Vivo and Phantom Lung Lesions.Tomography. 2021 Feb 9;7(1):55-64. doi: 10.3390/tomography7010005. eCollection 2021 Mar. Tomography. 2021. PMID: 33681463 Free PMC article.
-
Accurate Tumor Delineation vs. Rough Volume of Interest Analysis for 18F-FDG PET/CT Radiomics-Based Prognostic Modeling inNon-Small Cell Lung Cancer.Front Oncol. 2021 Oct 18;11:726865. doi: 10.3389/fonc.2021.726865. eCollection 2021. Front Oncol. 2021. PMID: 34733779 Free PMC article.
-
A transfer learning approach to facilitate ComBat-based harmonization of multicentre radiomic features in new datasets.PLoS One. 2021 Jul 1;16(7):e0253653. doi: 10.1371/journal.pone.0253653. eCollection 2021. PLoS One. 2021. PMID: 34197503 Free PMC article.
References
-
- Bray F., Ferlay J., Soerjomataram I., Siegel R.L., Torre L.A., Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424. - PubMed
-
- Visvikis D., Cheze Le Rest C., Jaouen V., Hatt M. Artificial intelligence, machine (deep) learning and radio(geno)mics: definitions and nuclear medicine imaging applications. Eur J Nucl Med Mol Imaging. 2019 Jul 6 in press, Epub ahead of print. - PubMed
-
- Hatt M., Tixier F., Visvikis D., Cheze Le Rest C. Radiomics in PET/CT: more than meets the eye? J Nucl Med. 2017;58:365–366. - PubMed
-
- Welch M.L., McIntosh C., Haibe-Kains B., Milosevic M.F., Wee L., Dekker A. Vulnerabilities of radiomic signature development: the need for safeguards. Radiother Oncol J Eur Soc Ther Radiol Oncol. 2019;130:2–9. - PubMed